Text Size

Treatment of Schizophrenia Through Internet-Based Psychoeducation

This study has been completed.
Sponsor:
Information provided by:
National Institute of Mental Health (NIMH)
ClinicalTrials.gov Identifier:
NCT00051233
First received: January 7, 2003
Last updated: November 17, 2005
Last verified: November 2005
History of Changes

January 7, 2003
November 17, 2005
January 2003
Not Provided
Not Provided
Not Provided
Complete list of historical versions of study NCT00051233 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Treatment of Schizophrenia Through Internet-Based Psychoeducation
Schizophrenia Patient and Family Continuity of Care

The purpose of this study is to assess the effectiveness of a Web-based psychoeducational program in helping people with schizophrenia and their families manage the disease.

This study will provide a comprehensive psychoeducational program which includes education, social support, information, coping strategies, and guidance from mental health, social services, and medical professionals. This study will work to reduce relapse, facilitate patient rehabilitation, decrease family distress, and improve family well being.

Patients and their families participate in an in-person Psychoeducational Survival Skills Workshop that is designed to provide patients and their families with basic information about schizophrenia and its treatment. After the workshop, participants are provided with 6 Web-based modules that are designed to increase mental health and schizophrenia knowledge. Patient relapse, family distress, family knowledge of schizophrenia, and data on user's acceptance and utilization are measured to determine the intervention's effectiveness.
Interventional
Phase 2
Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment
  • Schizophrenia
  • Schizoaffective Disorder
Procedure: World Wide Web-Based Psychoeducation
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
40
January 2005
Not Provided

Inclusion Criteria

  • DSM-IV diagnosis of schizophrenia or schizoaffective disorder
  • At least 4 hours/week in-person contact with a family member
  • Primary caregiver with a telephone
  • Patient and primary caregiver speak and read English

Exclusion Criteria:

  • Enrolled in another clinical trial
  • Evidence of organic brain syndrome
  • Current alcohol or substance abuse that could explain the presenting index psychotic episode
  • DSM-IV diagnosis of psychoactive substance dependency
Both
14 Years to 55 Years
Yes
Contact information is only displayed when the study is recruiting subjects
United States
 
NCT00051233
R01 MH63484, DSIR SE-DR
Not Provided
Not Provided
National Institute of Mental Health (NIMH)
Not Provided
Principal Investigator: Armando J Rotondi University of Pittsburgh
National Institute of Mental Health (NIMH)
November 2005

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP